Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)

NCT04778813 is registered in ClinicalTrials.gov with Centre national de recherche et de formation sur le paludisme as lead sponsor.

NCT NCT04778813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)
Lead sponsor
Centre national de recherche et de formation sur le paludisme
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2021
Completion date
June 1, 2022
Enrollment
1,050 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burkina faso, malaria